Business UpdateMay 28, 2026, 08:32 AM
Celcuity CEO to Present at Jefferies & Goldman Sachs Conferences
AI Summary
Celcuity Inc. announced that its Chief Executive Officer, Brian Sullivan, will present at two upcoming investor conferences. He is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, and at the Goldman Sachs 47th Annual Global Healthcare Conference on Wednesday, June 10, 2026. Live webcasts of both presentations will be available, with replays accessible shortly after the events on the company's investor relations website.
Key Highlights
- Celcuity CEO Brian Sullivan to present at Jefferies Global Healthcare Conference on June 4, 2026.
- CEO Sullivan to present at Goldman Sachs Global Healthcare Conference on June 10, 2026.
- Both presentations will feature a fireside chat with the CEO.
- Live webcasts and replays will be available for both investor events.
- Celcuity is a clinical-stage biotechnology company focused on solid tumor therapies.
- Lead candidate gedatolisib is in Phase 3 trials for breast cancer (VIKTORIA-1, VIKTORIA-2).
- Gedatolisib is also in a Phase 1b/2 trial for prostate cancer (CELC-G-201).
Price Impact
More from CELC